Public healthcare occurs when the costs associated with healthcare are financed publicly, by a governing body. A major goal of public healthcare is to increase access to a greater number of people who could not otherwise afford the rising costs.
Date: June 29, 2021 Time: 9:00am (PDT), 12:00pm (EDT) This month’s LabRoots discussion titled “Laboratory Screening for Multiple Myeloma: A Nudge in the Direction of Guideline Co...
DATE: June 03, 2021 TIME: 7:00am PDT Dr. Anne Kornreich will discuss her career journey in laboratory medicine that began with hematology and progressed to a leadership role through addition...
Date: May 20, 2021 Time: 6:00am (PDT), 9:00am (EDT), 2:00pm (BST) In this webinar, Dr Rachel Marrington, Deputy Director, and Finlay MacKenzie, Director, at Birmingham Quality UK NEQAS, will...
Date: May 13, 2021 Time: 9:00am PDT The value proposition for laboratory medicine has long been theorized, estimated and debated. Despite decades of effort and intangible proof, the strategi...
The increasing use of prescription and non-medical prescription opioids has created a significant public health crisis. The rising rate of opioid-related deaths across North America has led...
Learning Objectives: 1. Participants will understand how cannabis works with the Endocannabinoid system and what is the Endocannabinoid system 2. Participants will understand how cannabis is...
Date: January 21, 2021 Time: 10:00am (PST) Abstract Learning Objectives Discuss Procalcitonin as a biomarker to help distinguish viral versus bacterial infection Review the literature suppor...
DATE: December 10, 2020 TIME: 9:00am PST, 12:00pm EST Health systems across the globe continue to be challenged with aging populations, rising chronic diseases and changing care models....
Date: November 19, 2020 Time: 10:00am (PST), 1:00pm (EST) 98% of in-patients will undergo a diagnostic test during a hospital stay.[1] With the increased focus on the accuracy of diagnostic...
Today's presentation will cover the following topics from the perspective of a NYC based Laboratory: What have we learned year to date about CoV-2 and specifically how diagnostic testing...
Cases of traumatic brain injury (TBI) have been steadily rising over the past decade with most common causes of injury observed among participants in contact sports, combat military personne...
Point-of-care testing (POCT) is destined to play a much greater role in chronic disease diagnosis and management. Advanced POCT systems are being developed to deliver less costly and more ac...
Biomarkers play a vital role in disease detection and treatment follow-up. It is important to note that the diseases in the early stage are typically treated with the greatest probability of...
More than 50,700 Americans died of opioid overdose in 2019, and more than 1.6 million Americans live with addiction to opioids. Moreover, more than 50 million Americans suffer from chronic p...
The opioid crisis is a uniquely American challenge. Many factors catalyzed this national nightmare and others continue to fuel it. This presentation delves into some of the major contributor...
The opioid crisis erupted from a tragic convergence of factors from the private and public sectors. Changing sensibilities on opioid use and abuse, perspectives on addiction and recovery, be...
Learning Objectives: 1. Discuss the disease state model of substance use disorder 2. Discuss the evidence surrounding common misconceptions regarding substance use disorder...
Substance use disorder (SUD) remains a highly stigmatized medical condition in the US. One of the most effective methods of treatment for SUD, specifically for opioid use disorder and alcoho...
Urine drug testing has become an essential part of the management of patients with chronic pain. Testing provides objective information regarding drug compliance, diversion, and abuse to med...
Date: June 29, 2021 Time: 9:00am (PDT), 12:00pm (EDT) This month’s LabRoots discussion titled “Laboratory Screening for Multiple Myeloma: A Nudge in the Direction of Guideline Co...
DATE: June 03, 2021 TIME: 7:00am PDT Dr. Anne Kornreich will discuss her career journey in laboratory medicine that began with hematology and progressed to a leadership role through addition...
Date: May 20, 2021 Time: 6:00am (PDT), 9:00am (EDT), 2:00pm (BST) In this webinar, Dr Rachel Marrington, Deputy Director, and Finlay MacKenzie, Director, at Birmingham Quality UK NEQAS, will...
Date: May 13, 2021 Time: 9:00am PDT The value proposition for laboratory medicine has long been theorized, estimated and debated. Despite decades of effort and intangible proof, the strategi...
The increasing use of prescription and non-medical prescription opioids has created a significant public health crisis. The rising rate of opioid-related deaths across North America has led...
Learning Objectives: 1. Participants will understand how cannabis works with the Endocannabinoid system and what is the Endocannabinoid system 2. Participants will understand how cannabis is...
Date: January 21, 2021 Time: 10:00am (PST) Abstract Learning Objectives Discuss Procalcitonin as a biomarker to help distinguish viral versus bacterial infection Review the literature suppor...
DATE: December 10, 2020 TIME: 9:00am PST, 12:00pm EST Health systems across the globe continue to be challenged with aging populations, rising chronic diseases and changing care models....
Date: November 19, 2020 Time: 10:00am (PST), 1:00pm (EST) 98% of in-patients will undergo a diagnostic test during a hospital stay.[1] With the increased focus on the accuracy of diagnostic...
Today's presentation will cover the following topics from the perspective of a NYC based Laboratory: What have we learned year to date about CoV-2 and specifically how diagnostic testing...
Cases of traumatic brain injury (TBI) have been steadily rising over the past decade with most common causes of injury observed among participants in contact sports, combat military personne...
Point-of-care testing (POCT) is destined to play a much greater role in chronic disease diagnosis and management. Advanced POCT systems are being developed to deliver less costly and more ac...
Biomarkers play a vital role in disease detection and treatment follow-up. It is important to note that the diseases in the early stage are typically treated with the greatest probability of...
More than 50,700 Americans died of opioid overdose in 2019, and more than 1.6 million Americans live with addiction to opioids. Moreover, more than 50 million Americans suffer from chronic p...
The opioid crisis is a uniquely American challenge. Many factors catalyzed this national nightmare and others continue to fuel it. This presentation delves into some of the major contributor...
The opioid crisis erupted from a tragic convergence of factors from the private and public sectors. Changing sensibilities on opioid use and abuse, perspectives on addiction and recovery, be...
Learning Objectives: 1. Discuss the disease state model of substance use disorder 2. Discuss the evidence surrounding common misconceptions regarding substance use disorder...
Substance use disorder (SUD) remains a highly stigmatized medical condition in the US. One of the most effective methods of treatment for SUD, specifically for opioid use disorder and alcoho...
Urine drug testing has become an essential part of the management of patients with chronic pain. Testing provides objective information regarding drug compliance, diversion, and abuse to med...
Opens in a new windowOpens an external siteOpens an external site in a new window
Follow
